Literature DB >> 12914547

Monoamine metabolism changes following the mouse forced swimming test but not the tail suspension test.

Caroline E Renard1, Eric Dailly, Denis J P David, Martine Hascoet, Michel Bourin.   

Abstract

Microdialysis, binding and behavioural studies have shown that the dopaminergic system plays a role in antidepressant treatment. It has been suggested that stress may provoke a modification in dopamine (DA) release in different brain areas and that the forced swimming test (FST), in its own accord as a stressor, may be responsible for this modification. Naive male Swiss mice, receiving saline solution, were used in two animal models of depression, the FST and the tail suspension test (TST). In order to understand the locomotor aspect of each test, groups of mice were studied for effects on locomotor activity. Following each test, mice were killed by cervical dislocation, brains were removed and concentrations of amines in the whole brain were analysed by high-performance liquid chromatography. DA concentration increased from 5 min of the FST, dihydroxyphénylacetate (DOPAC), from 20 min of FST and serotonin, from 8 min of FST. No modification of noradrenaline was observed during the FST and no modification of the neurotransmitter concentrations was observed during the TST. Following an FST of 2-min duration, a hypolocomotor effect was observed in the subsequent actimeter test. The same effect was observed after a TST of 8 min and onwards. This study confirms the fact that although these two tests are used to study depression, they involve different neuronal mechanisms.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12914547     DOI: 10.1046/j.1472-8206.2003.00160.x

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  37 in total

1.  Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.

Authors:  Abir T El-Alfy; Kelly Ivey; Keisha Robinson; Safwat Ahmed; Mohamed Radwan; Desmond Slade; Ikhlas Khan; Mahmoud ElSohly; Samir Ross
Journal:  Pharmacol Biochem Behav       Date:  2010-03-21       Impact factor: 3.533

2.  Identification of antidepressant drug leads through the evaluation of marine natural products with neuropsychiatric pharmacophores.

Authors:  Jeffrey A Diers; Kelly D Ivey; Abir El-Alfy; Jamaluddin Shaikh; Jiajia Wang; Anna J Kochanowska; John F Stoker; Mark T Hamann; Rae R Matsumoto
Journal:  Pharmacol Biochem Behav       Date:  2007-11-06       Impact factor: 3.533

3.  Cholecystokinin knock-down in the basolateral amygdala has anxiolytic and antidepressant-like effects in mice.

Authors:  C Del Boca; P E Lutz; J Le Merrer; P Koebel; B L Kieffer
Journal:  Neuroscience       Date:  2012-05-18       Impact factor: 3.590

4.  Brain Glycogen Decreases During Intense Exercise Without Hypoglycemia: The Possible Involvement of Serotonin.

Authors:  Takashi Matsui; Shingo Soya; Kentaro Kawanaka; Hideaki Soya
Journal:  Neurochem Res       Date:  2015-06-03       Impact factor: 3.996

5.  Behavioral effects of nicotinic antagonist mecamylamine in a rat model of depression: prefrontal cortex level of BDNF protein and monoaminergic neurotransmitters.

Authors:  Sawsan Aboul-Fotouh
Journal:  Psychopharmacology (Berl)       Date:  2014-10-15       Impact factor: 4.530

6.  Dissociation of heroin-induced emotional dysfunction from psychomotor activation and physical dependence among inbred mouse strains.

Authors:  G Ayranci; K Befort; L Lalanne; B L Kieffer; P-E Lutz
Journal:  Psychopharmacology (Berl)       Date:  2014-12-09       Impact factor: 4.530

7.  Enhanced cocaine responsiveness and impaired motor coordination in metabotropic glutamate receptor subtype 2 knockout mice.

Authors:  Yosuke Morishima; Tsuyoshi Miyakawa; Tomoyuki Furuyashiki; Yasuhiro Tanaka; Hiroshi Mizuma; Shigetada Nakanishi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-07       Impact factor: 11.205

8.  Augmentation effect of combination therapy of aripiprazole and antidepressants on forced swimming test in mice.

Authors:  Michel Bourin; Franck Chenu; Corina Prica; Martine Hascoët
Journal:  Psychopharmacology (Berl)       Date:  2009-06-11       Impact factor: 4.530

9.  Increased c-fos expression in the central nucleus of the amygdala and enhancement of cued fear memory in Dyt1 DeltaGAG knock-in mice.

Authors:  Fumiaki Yokoi; Mai T Dang; Courtney A Miller; Andrea G Marshall; Susan L Campbell; J David Sweatt; Yuqing Li
Journal:  Neurosci Res       Date:  2009-07-18       Impact factor: 3.304

Review 10.  Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands.

Authors:  Elaine C Gavioli; Girolamo Calo'
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-02-21       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.